Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research

Liusheng Wu(Anhui Medical University), Xiaoqiang Li(Chinese Academy of Sciences), Yu Feng(Tianjin Medical University), Pengcheng Xu(Peking University Shenzhen Hospital), Qi Liu(Peking University Shenzhen Hospital), Xiaoya Yu(Southern Medical University), Yanfeng Zhong(Peking University Shenzhen Hospital), Le Lv(Chinese Academy of Sciences), Xin Ruan(Shantou University), Jixian Liu(Dongguan University of Technology), Dingwang Wu(Peking University Shenzhen Hospital)
Anti-Cancer Drugs
August 9, 2022
10.1097/cad.0000000000001319
Cited by 120

Related Papers

Tailoring Highly Ordered Graphene Framework in Epoxy for High-Performance Polymer-Based Heat Dissipation Plates
|ACS Nano|2021|148
Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis
|Biomedicines|2022|121
Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19
|Aging|2021|115
Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
|Biomedicines|2023|112
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
|Vaccines|2024|106